Impact of baseline renal function on outcomes of renal artery stenting in hypertensive patients

Journal of Clinical Hypertension

Volumn 11, Issue 11, 2009, Pages 615-620

  Singer, Gregory M ^a   Remetz, Michael S ^a   Curtis, Jeptha P ^a   Setaro, John F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; COMORBIDITY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENAL ARTERY; STENT; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY; MALE; PROGNOSIS; RENAL ARTERY; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 70449382517     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2009.00167.x     Document Type: Article

References (28)

1. Blum U, Krumme B, Flugel P. Treatment of ostial renal-artery stenoses with vascular endoprostheses after unsuccessful balloon angioplasty. N Engl J Med 1997, 336:459-465.
2. Van de Ven PJ, Kaatee R, Beutler JJ. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999, 353:282-286.
3. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation 2005, 112:1362-1374.
4. Textor SC, Lerman L, McKusick M. The uncertain value of renal artery interventions: where are we now?. JACC Cardiovasc Interv 2009, 2:175-182.
5. Rocha-Singh KJ, Mishkel GJ, Katholi RE. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv 1999, 47:167-172.
6. Dorros G, Jaff M, Mathiak L. Multicenter Palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Catheter Cardiovasc Interv 2002, 55:182-188.
7. Conlon PJ, Athirakul K, Kovalik E. Survival in renal vascular disease. J Am Soc Nephrol 1998, 9:252-256.
8. Iannone LA, Underwood PL, Nath A. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Cathet Cardiovasc Diagn 1996, 37:243-250.
9. Conlon PJ, Little MA, Pieper K. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001, 60:1490-1497.
10. Levey AS, Coresh J, Balk E. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
11. Levey AS, Bosch JP, Lewis JB. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
12. Chobanian AV, Bakris GL, Black HR. The Seventh Report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high BP. JAMA 2003, 289:2560-2572. National High BP Education Program Coordinating Committee
13. Singer GM, Setaro JF, Curtis JP. Distal embolic protection during renal artery stenting: impact on hypertensive patients with renal dysfunction. J Clin Hypertens (Greenwich) 2008, 10:830-836.
14. Moser M, Setaro J. Resistant or difficult-to-control hypertension. N Engl J Med 2006, 355:385-392.
15. Epstein FH. Oxygen and renal metabolism. Kidney Int 1997, 51:381-385.
16. Zhuo JL, Imig JD, Hammond TG. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension. Role of AT1 receptor. Hypertension 2002, 39:116-121.
17. Sadjadi J, Puttaparthi K, Li L. Upregulation of autocrine-paracrine reninangiotensin systems in chronic renovascular hypertension. J Vasc Surg 2002, 36:386-392.
18. Pipinos II, Nypaver TJ, Moshin SK. Response to angiotensin inhibition in rats with sustained renovascular hypertension correlates with response to removing renal artery stenosis. J Vasc Surg 1998, 28:167-177.
19. O'Neill EA, Hansen KJ, Canzanello VJ. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg 1992, 58:485-490.
20. Wollenweber J, Sheps S, Davis G. Clinical course of atherosclerotic renovascular disease. Am J Cardiol 1968, 21:60-71.
21. Johansson M, Herlitz H, Jensen G. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999, 17:1743-1750.
22. Kennedy DJ, Colyer WR, Brewster PS. Renal insufficiency as a predictor of adverse events and mortality after renal artery stent placement. Am J Kidney Dis 2003, 42:926-935.
23. Weiner DE, Tighiouart H, Amin MG. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
24. Webster J, Marshall F, Abdalla M. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998, 12:329-335.
25. van Jaarsveld BC, Krijnen P, Pieterman H. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med 2000, 14:1007-1014.
26. Plouin PF, Chatellier G, Darne B. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998, 31:823-829.
27. Cooper CJ, Haller ST, Colyer W. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008, 117:2752-2760.
28. Murphy TP, Cooper CJ, Dworkin LD. The cardiovascular outcomes with renal atherosclerotic lesions (CORAL) study: rationale and methods. J Vasc Interv Radiol 2005, 16:1295-1300.